Viatris (VTRS) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Powered by 
Analysis
Viatris (VTRS) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -97.39% |
| 3 | Dr Reddys Laboratories | 9.88 Bn | 9.71 Bn | 396.53 Mn | -85.68% |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.35 Bn | 507.63 Mn | 2.10 Bn | 95.71% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -649.91% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 996.39 Mn | 706.27 Mn | 93.47 Mn | -11.17% |
| 9 | Fennec Pharmaceuticals | 401.41 Mn | 360.16 Mn | 17.15 Mn | 12,688.80% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -97.39% |
| Mar 31, 2026 | 97.34% |
| Dec 31, 2025 | -7.71% |
| Sep 30, 2025 | -3.64% |
| Jun 30, 2025 | 221.45% |
| Mar 31, 2025 | -1,793.80% |
| Dec 31, 2024 | 53.63% |
| Sep 30, 2024 | -51.40% |
| Jun 30, 2024 | -164.04% |
| Mar 31, 2024 | -45.83% |
| Dec 31, 2023 | -135.72% |
| Sep 30, 2023 | -12.69% |
| Jun 30, 2023 | -31.68% |
| Mar 31, 2023 | -43.79% |
| Dec 31, 2022 | -161.35% |
| Sep 30, 2022 | 55.30% |
| Jun 30, 2022 | 1,414.70% |
| Mar 31, 2022 | 407.18% |
| Dec 31, 2021 | 91.42% |
| Mar 31, 2021 | -202.25% |